BioTech 365

FEBRUARY 17, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s tirzepatide aces 2 more late-phase diabetes trials.Lilly’s tirzepatide aces 2 more late-phase diabetes trials ntaylor Wed, 02/17/2021 – 08:30 from FierceBiotech: Biotech [link].

Trials 40

Trials Research 40

BioTech 365

AUGUST 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Unraveling the link between migraines and protection against diabetes.Unraveling the link between migraines and protection against diabetes klahucik Wed, 08/25/2021 – 11:46 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

DECEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Preventing Type 1 diabetes by targeting a T-cell protein.Preventing Type 1 diabetes by targeting a T-cell protein aliu Wed, 12/09/2020 – 08:40 from FierceBiotech: Biotech [link].

Protein 40

Protein Research 40

BioTech 365

SEPTEMBER 24, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Poxel posts phase 3 diabetes data ahead of approval decision.Poxel posts phase 3 diabetes data ahead of approval decision ntaylor Thu, 09/24/2020 – 07:43 from FierceBiotech: Biotech … Continue reading →

Research 40

Research 40

BioTech 365

OCTOBER 30, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial.Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial ntaylor Fri, 10/30/2020 – 06:58 from … Continue reading →

Trials 40

Trials Drugs Research 40

BioTech 365

JUNE 28, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ADA: TB vaccine repurposed in Type 1 diabetes restores gene expression in key immune cells.ADA: TB vaccine repurposed in Type 1 diabetes restores gene expression in key … Continue reading →

Gene Expression 40

Gene Expression Gene Vaccination Vaccine 40

BioTech 365

MARCH 4, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture.Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture … (..)

Research 40

Research 40

BioTech 365

JANUARY 18, 2022

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA.Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it … Continue reading →

Research 40

Research 40

BioTech 365

DECEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3.Lilly’s

Research 40

Research 40

BioTech 365

SEPTEMBER 30, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly adds liver fat, CGM blood sugar data to mountain of evidence on hot diabetes prospect tirzepatide.Lilly adds liver fat, CGM blood sugar data to mountain of … Continue reading →

Research 40

Research 40

BioTech 365

OCTOBER 26, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Wrinkled ‘super pea’ could be added to foods to reduce diabetes risk.A

Research 40

Research 40

BioTech 365

MAY 25, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Provention Bio, in need of AdComm’s support for diabetes drug, may have what it needs to satisfy the FDA.Provention Bio, in need of AdComm’s support for diabetes … Continue reading →

Drugs 40

Drugs Research 40

BioTech 365

AUGUST 14, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Amgen-partnered researchers treat diabetes in mice by silencing IL-2’s inflammatory power.Amgen-partnered researchers treat diabetes in mice by silencing IL-2’s inflammatory power aliu Fri, 08/14/2020 – 06:11 (..)

Research 40

Research 40

Pharmaceutical Technology

MARCH 1, 2023

Also in this month’s issue, we take a look at the innovative type 1 diabetes therapy by Provention Bio called Tzield. More than a century after an individual with type 1 diabetes was treated with insulin for the first time, the FDA approved Tzield, the first and only treatment to delay the onset of type 1 diabetes.

Production 130

Production Insulin FDA Approval Pharma Production 130

XTalks

MARCH 15, 2024

In a news release , Lilly announced it, “selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists.” In the US, around 98 million adults, which is about one in three, have prediabetes and nearly 40 million adults have diabetes.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

Drug Channels

JULY 29, 2020

In this issue: Pricing problems for diabetes treatments Controversy over Regeneron’s copay support Massachusetts concedes that coupons help some patients (but accumulators hurt) A 2020 update to my all-time favorite chart Plus, thoughtful perspectives on diversity from AmerisourceBergen CEO Steve Collis.

Pharmacy 52

Pharmacy Drugs Sales 52

Sciensano

NOVEMBER 28, 2023

A new four-year project called the Joint Action on Cardiovascular Diseases and Diabetes ( JACARDI ) was launched in Rome on 27 November 2023. The prevalence of diabetes has also risen dramatically, with the number of adults living with the condition nearly doubling in the past decade, reaching 32.3 million in 2019.

Development 98

Development Marketing Research 98

World of DTC Marketing

MAY 16, 2022

Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. Another said, as the news about weight loss circulates, he expects a lot of patients to ask for the product.

Drugs 218

Drugs Pharma Companies Clinical Trials Clinical Trials 218

Medical Xpress

MARCH 30, 2023

Centers for Disease Control, one out of every three adults in the United States has prediabetes, a condition marked by elevated blood sugar levels that could lead to the development of type 2 diabetes. The good news is that if it is detected early, prediabetes can be reversed through lifestyle changes such as improved diet and exercise.

Development 70

Development 70

Scienmag

MAY 25, 2022

Researchers will delve into the latest research in diabetes, obesity, thyroid and other endocrine conditions during the Endocrine Society’s ENDO 2022 news conferences June 11-14. The press conferences will feature select abstracts that are being presented at ENDO 2022, the Endocrine Society’s annual meeting.

Research 84

Research 84

STAT News

FEBRUARY 22, 2023

… Eli Lilly says that all doses of its new Mounjaro diabetes drug are now available after social-media enthusiasm about weight-loss benefits sparked a two-month-long shortage , Bloomberg News tells us. last May to help people with type 2 diabetes control their blood sugar levels. The drug was approved in the U.S.

Drugs 98

Drugs Doctors Doctor 98

Scienmag

APRIL 1, 2022

University of Leeds news Credit: Lee Roberts University of Leeds news Embargo: Friday 1 April, 10am London time Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found.

81

81

Scienmag

OCTOBER 6, 2021

A culturally grounded, community approach to improving the health of Latino youth at risk for Type 2 diabetes is expanding to include entire families.

Research 79

Research Medicine 79

Drug Discovery World

JULY 7, 2023

News round-up for 3-7 July by DDW Digital Content Editor Diana Spencer. In other headline news, the FDA approved the first cellular therapy for type 1 diabetes which could allow some patients to become insulin-independent, and a new study linked severe Covid-19 outcomes with high levels of antibiotics use.

Drugs 52

Drugs FDA Approval Insulin Gene 52

Drug Discovery World

NOVEMBER 28, 2022

DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news. . The week has also seen the first immunomodulatory treatment for type 1 diabetes approved in the US and a possible breakthrough in the treatment of neurodegenerative disorders.

Gene Therapy 52

Gene Therapy Gene Regulation Drugs 52

Pharmaceutical Technology

APRIL 21, 2023

In a statement emailed to Endpoints News , AstraZeneca (AZ) disclosed intentions to terminate its clinical program for its daily glucagon-like peptide-1 receptor glucagon co-agonist (GLP-1RA/GCGR) cotadutide, in favour of focusing on the development of AZD9550, its once-weekly injectable GLP-1RA/GCGR.

Trials 130

Trials Marketing Development Hormones 130

Drug Discovery World

APRIL 28, 2023

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. The stories cover the efforts by research teams to discover innovative novel drugs for geographic atrophy, HIV, lung cancer, anxiety and diabetes. The post This week in drug discovery (24-28 April) appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Life Science Clinical Trials Clinical Trials 52

pharmaphorum

MARCH 31, 2022

More than 250,000 people living with type 1 diabetes in the UK will be offered real-time continuous glucose monitoring (CGM) technology, reducing their reliance on fingerprick testing, according to NICE. At the moment, flash CGM has been rolled out to around half of patients with type 1 diabetes by NHS England. Exciting news!

Insulin 52

Insulin Clinical Trials Clinical Trials Trials 52

XTalks

SEPTEMBER 28, 2023

Related: Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate Bayer’s new over-the-counter (OTC) cold, flu and allergy med Astepro not only emerged as the most viewed new pharma TV ad in the first half of the year, but also topped iSpot.tv’s list of all new brand ads with 7.4

Drugs 105

Drugs Allergies Branding FDA Approval 105

Drug Discovery World

JULY 10, 2023

In other headline news, the FDA approved the first cellular therapy for type 1 diabetes which could allow some patients to become insulin-independent, and a new study linked severe Covid-19 outcomes with high levels of antibiotics use.

Insulin 52

Insulin FDA Approval Drugs Trials 52

Pharmaceutical Technology

MAY 30, 2023

Vabysmo is administered into the eye to treat patients with neovascular (wet) age-related macular degeneration (AMD) and diabetic macular oedema (DME). Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection).

Antibody 130

Antibody Drugs Research 130

Drug Discovery World

DECEMBER 9, 2022

News round-up for 5-9 December by DDW Digital Content Editor Diana Spencer. Teamwork makes the dream work’ this week, with the launch of new partnerships to further the development of precision drugs in neurodevelopmental disorders, lung cancer and rare paediatric diseases. The top stories: .

Drugs 52

Drugs Vaccination Vaccine Trials 52

XTalks

FEBRUARY 2, 2023

million Americans are living with type 1 diabetes (T1D). We knew this day would come, but we couldn’t have achieved it without the support of the entire diabetes community, including the FDA,” said Howard Look, CEO, and co-founder of Tidepool, in the company’s press release.

Insulin 52

Insulin Marketing Life Science Development 52

XTalks

SEPTEMBER 23, 2020

Related: Risk Assessment Tool Identifies Diabetic Patients that Benefit Most from SGLT2 Inhibitor Treatment. Droplet Micron was designed to help break this regular and continued cycle of anxiety so that people injecting medications to help manage their diabetes feel more at ease each time they perform an injection. in a news release.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

XTalks

JUNE 3, 2021

A new Australian study suggests that eating fruit may lead to a reduced risk of developing type 2 diabetes. Researchers at the Edith Cowan University’s (ECU) Institute for Nutrition Research in Perth, Australia found that consuming at least two servings of fruit a day was linked to 36 percent lower odds of developing type 2 diabetes.

Insulin 59

Insulin Development Research Doctors 59

STAT News

NOVEMBER 18, 2022

The first therapy that delays the onset of type 1 diabetes received approval from the U.S. million people have type 1 diabetes in the U.S., according to the American Diabetes Association, including 244,000 children and adolescents. Type 1 affects 8% of everyone with diabetes. Food and Drug Administration , CNN tells us.

Insulin 98

Insulin FDA Approval Production Pharmacy 98

The Pharma Data

OCTOBER 16, 2020

16, 2020 — For patients with diabetes mellitus and obesity, bariatric surgery (BS) is associated with a reduced prevalence of pancreatic cancer compared with no BS, according to a study presented at UEG Week Virtual 2020, held Oct. A total of 1,435,350 patients with concomitant diabetes mellitus and obesity were identified; of these, 0.7

Research 52

Research 52